)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Modus Therapeutics (MODTX) investor relations material
Modus Therapeutics Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary26 Nov, 2025
Executive summary
Completed patient enrollment for Part 1 of the Phase IIa sevuparin study in CKD anemia; Part 2 set to begin in Q4 2025 following regulatory approval in Italy.
Raised SEK 28.3 million in an oversubscribed rights issue, extending cash runway through end-2026 and supporting ongoing clinical activities.
Presented new preclinical data showing sevuparin improved anemia and kidney function in CKD models, reinforcing its hepcidin-lowering mechanism.
Strengthened global outreach and partnerships, including participation in major industry events and a new Certified Adviser appointment.
Financial highlights
Q3 2025 loss after tax: TSEK 4,342 (vs. 2,989 in Q3 2024); loss per share: SEK 0.08 (unchanged year-over-year).
9M 2025 loss after tax: TSEK 13,223 (vs. 10,831 in 9M 2024); loss per share: SEK 0.31 (vs. 0.30).
Cash flow from operations Q3: TSEK -5,590 (vs. -3,971); 9M: TSEK -13,072 (vs. -11,060).
Cash and cash equivalents at period end: TSEK 16,534 (vs. 7,999 in Q3 2024).
Shareholders’ equity at period end: TSEK 14,549 (vs. 6,851 in Q3 2024).
Outlook and guidance
Part 2 of the Phase IIa CKD anemia study to initiate in Q4 2025, with regulatory approval and site activation underway.
Funding secured to support operations and clinical development through end-2026, with potential for further proceeds from warrant exercises.
Continued focus on advancing sevuparin in CKD anemia, with future development planned in severe malaria and sepsis.
What is the cash runway without TO 2026 exercise?
Impact of new preclinical data on CKD strategy?
What is the strategy for malaria development?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Modus Therapeutics earnings date
Q4 202525 Feb, 2026
Next Modus Therapeutics earnings date
Q4 202525 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Modus Therapeutics Holding is a clinical-stage biopharmaceutical company developing therapies for diseases related to inflammation and blood flow disorders. Its lead programs focus on treatments for conditions such as sepsis and sickle cell disease. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Nasdaq First North Growth Market.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage